How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

8,213 results for

Medication Causes of Headache

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Nutrition for Post-Traumatic Headache

Military Medical Center Fort Belvoir Community Hospital Womack Army Medical Center University of North Carolina, Chapel Hill National Institutes of Health (NIH) Information provided by (Responsible Party): Kimbra Kenney, Uniformed Services University of the Health Sciences Study Details Study Description Go to Brief Summary: The purpose of this multi-site study is to evaluate the efficacy of a high omega-3/low omega-6 dietary intervention (the H3-L6 Diet) vs. a Control Diet in reducing headache pain (...) . A survey of pain, the Total Body Pain Scale, will be administered at baseline and at the end of the 12-week diet intervention. The outcome measure is a reduction in non-headache pain as measured by the survey at baseline and at the end of the diet intervention. To explore the potential of the H3-L6 intervention for decreasing acute pain medication usage [ Time Frame: Daily on-line diary entry during the 16-week study ] Compared to the Control Diet, the H3-L6 Diet may produce significant improvement

2017 Clinical Trials

82. EFFECTS OF MIOFASCIAL RELEASE AND PERCUTANEOUS MICROELETROLYSIS IN TYPE HEADACHE

, 2017 Last Update Posted : July 21, 2017 See Sponsor: Rodrigo Marcel Valentim da Silva Information provided by (Responsible Party): Rodrigo Marcel Valentim da Silva, Estácio Ponta Negra Study Details Study Description Go to Brief Summary: A headache is a more common disorder and one that prevails over a lifetime of much of the population. Among the causes are in the stress and spasms of the pericranial musculature, presence of painful sensitivity in the region, decrease of pain threshold (...) , and a presence of trigger points (PGs) that can also cause as headaches. The solutions for health and health, in addition to Percutaneous Microelectrolysis (MEP®), which is used in the application of low intensity galvanic current through the acupuncture needle. Although it is a very common pathology, it is still little studied and a lack of information is a question of solutions such as crisis of care. This work justifies the negative bones of CTT in university students, as this has repercussions

2017 Clinical Trials

83. The Sphenopalatine Ganglion Block for Post-dural Puncture Headache

scores at 4 hours after performing the sphenopalatine block as compared to baseline VAS scores. Condition or disease Intervention/treatment Phase Post-Dural Puncture Headache Procedure: Sphenopalatine ganglion block Not Applicable Detailed Description: Post-dural puncture headache (PDPH) is a major cause of morbidity in postpartum patients who received neuraxial anesthesia for labor analgesia or cesarean delivery. The headache in PDPH is thought to be due to loss of cerebrospinal fluid causing (...) downward traction on the meninges with parasympathetic ally mediated reflex vasodilation of the meningeal vessels. The epidural blood patch is currently the gold-standard treatment for postdural puncture headache, however it is an invasive procedure with possible risks and complications including bleeding, infection, pain, hematoma, neurologic complications, and repeat dural puncture. Patients are often offered conservative treatment including medications, bed rest, abdominal binders, and fluids

2017 Clinical Trials

84. Approach to Chronic Secondary Headache: A Case Report on Unusual Drug Side Effects (PubMed)

Approach to Chronic Secondary Headache: A Case Report on Unusual Drug Side Effects In this article, we present the case of a 12-year-old female child who complained of bilateral temporal and frontal headache for 2 to 3 months with nausea and vomiting. Physical examination revealed right-sided sixth cranial nerve palsy and papilledema in ophthalmoscopy. To find the cause of increased intracranial pressure, the patient underwent brain imaging and brain MRI showed no abnormality. Ultimately (...) , lumbar puncture (LP) was performed and cerebrospinal fluid (CSF) pressure was 280 mmH2O with normal chemistry. We considered pseudotumor cerebri as the first diagnosis. LP was carried out three times and 30cc of CSF was tapped each time. Finally, patient's headache and papilledema improved and physical examination after 6 months showed no sign of raised intracranial pressure (rICP). The most prominent point in her past medical history was the use of growth hormone (GH) for 2 years. No sign of symptom

Full Text available with Trip Pro

2017 Iranian journal of medical sciences

85. Capsaicin in Treatment of Rhinogenic Headache

. This study aims to evaluate capsaicin impact on headaches attributed to the nose and paranasal sinus distribution. Interventions, evaluations, and follow-up: Subjects are recruited from an Otolaryngology clinic, where a formal headache questionnaire is administered in-office, and standard endoscopy is performed in office to rule out confounding causes of headache and sinonasal disease. Written instructions are provided and consent obtained. A symptom journal is provided. Subjects are randomly selected (...) to receive two bottles of either eucalyptol spray (placebo) or sinus buster (capsaicin) spray and are blinded to the content of the spray bottle. They are instructed to use the nasal spray one to two times daily. Subjects are permitted to continue to take headache medication as needed, but it must be recorded in their symptom journal. The journal is completed daily, and includes medication use, a headache pain score, and side effect log. Additionally, subjects fill out SinoNasal Outcome test (SNOT)22

2017 Clinical Trials

86. Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics

like your dentist uses. Some times the numbing agent is combined with another medication that causes drowsiness and relieves pain called a narcotic. One of the risks associated with having this kind of pain relief is unintentional puncture of a sheath of tissue that surrounds and protects the spinal cord when inserting the needle. This sheath is called the dura. This would cause the fluid surrounding the spinal cord to leak out and this would cause a headache. This headache is called a post-dural (...) puncture headache [PDPH]. The headache can be mild or severe. Rarely, PDPH can be serious and cause bleeding or small clots in the brain and damage to nerves that come out of the brain. The purpose of this study is to test the use of a technique that uses a hollow cotton swab [no needles] to numb a nerve cell cluster that sits at the very back of the nasal cavity. The anatomical name for this nerve cell cluster is the sphenopalatine ganglion. This has been done before at BJH and other hospitals

2017 Clinical Trials

87. Impact of Co-existing Vascular Headache on Symptom Relief After Endoscopic Sinus Surgery (PubMed)

Impact of Co-existing Vascular Headache on Symptom Relief After Endoscopic Sinus Surgery Vascular headache and chronic rhinosinusitis (CRS) are diseases that share similar symptoms and demographics, including headache, facial pain and nasal symptoms. Contribution of chronic sinusitis as a cause of chronic headache is controversial, as there are scarce studies to know incidence of vascular headache in patients with CRS. To evaluate incidence of vascular headache in patients with CRS. Using (...) descriptive study design, group of 100 patients with symptoms of CRS with headache were included in study. Patients underwent surgical management and 3% managed medically. Patients were assessed for associated factors with headache and further evaluated for persistence of headache postoperatively. Inferential statistics was done by Chi square test using SPSS for Windows Software (Version 21.0). Leading symptoms of CRS were headache (100%), nasal obstruction (93%), and nasal discharge (90%). Pre-treatment

Full Text available with Trip Pro

2017 Indian Journal of Otolaryngology and Head & Neck Surgery

88. Primary headache disorders in the adult general population of Pakistan – a cross sectional nationwide prevalence survey (PubMed)

the four provinces of Pakistan: Punjab, Sindh, Khyber Pakhtunkhwa and Baluchistan. We randomly selected and visited rural and urban households in each. One adult member (18-65 years) of each household, also randomly selected, was interviewed by a trained non-medical interviewer from the same location using a previously-validated structured questionnaire translated into Urdu, the national language. We estimated 1-year prevalences of the headache disorders of public-health importance and examined (...) %] (male 51.2% [49.7-52.7%], female 37.9% [36.4-39.4%]), of probable medication-overuse headache 0.7% [0.5-1.0%] (male 0.7% [0.5-1.0%], female 0.8% [0.5-1.1%]) and of other headache on ≥15 days/month 7.4% [6.6-8.2%] (male 4.4% [3.8-5.0%], female 10.4% [9.5-11.3%]). Migraine was more prevalent in females by a factor of 3:2 although this association barely survived (P = 0.039) after correcting for other factors. TTH was more prevalent in males by about 4:3 (P = 0.026). All headache and migraine were age

Full Text available with Trip Pro

2017 The journal of headache and pain

89. Prevalence and burden of headache disorders in Lithuania and their public-health and policy implications: a population-based study within the Eurolight Project (PubMed)

%). Gender-adjusted 1-year prevalences were: any headache 74.7%; migraine 18.8%; tension-type headache (TTH) 42.2%; all headache on ≥15 days/month 8.6%; probable medication-overuse headache (pMOH) 3.2%. Migraine (OR: 3.6) and pMOH (OR: 2.9) were associated with female gender. All headache types except TTH were associated with significantly diminished quality of life. Migraine caused a mean 4.5% loss in paid worktime per affected male and 3.5% per affected female. Lost per-person times due to TTH were (...) Prevalence and burden of headache disorders in Lithuania and their public-health and policy implications: a population-based study within the Eurolight Project The Eurolight project assessed the impact of headache disorders in ten EU countries, using the same structured questionnaire but varying sampling methods. In Lithuania, sample selection employed methods in line with consensus recommendations for population-based burden-of-headache studies.The survey was cross-sectional. We identified

Full Text available with Trip Pro

2017 The journal of headache and pain

90. The burden of headache disorders in Ethiopia: national estimates from a population-based door-to-door survey (PubMed)

The burden of headache disorders in Ethiopia: national estimates from a population-based door-to-door survey Headache disorders are the third-highest cause of disability worldwide, with migraine and medication-overuse headache (MOH) the major contributors. In Ethiopia we have shown these disorders to be highly prevalent: migraine 17.7%, TTH 20.6%, probable MOH (pMOH) 0.7%, any headache yesterday (HY) 6.4%. To inform local health policy, we now estimate disability and other burdens attributable (...) to headache in this country.In a cross-sectional survey using cluster-randomized sampling, we visited households unannounced in four diverse regions (urban and rural) of Ethiopia. We interviewed one member (18-65 years old) of each household using the HARDSHIP structured questionnaire. Screening and diagnostic questions based on ICHD-II were followed by burden enquiry in multiple domains. We estimated disability using disability weights (DWs) from the Global Burden of Disease 2013 study.We interviewed

Full Text available with Trip Pro

2017 The journal of headache and pain

91. Extracranial origin of headache (PubMed)

Extracranial origin of headache To summarize recent clinical and preclinical studies on extracranial pathophysiologies in migraine. It challenges the opinion-based notion that the headache phase of migraine occurs without input from peripheral nociceptors or is caused solely by activation of intracranial nociceptors supplying dural and cerebral vasculature.Data that support a scenario by which migraine can originate extracranially include the perception of imploding headache that hurts outside (...) the calvaria reduces frequency of migraine headache.These findings seeks to shift clinical practice from prophylactically treating chronic migraine solely with medications that reduce neuronal excitability to treating irritated nociceptors or affected tissues. The findings also seeks to shift current research from focusing solely on central nervous system alterations and activation of meningeal nociceptors as a prerequisite for studying migraine.

Full Text available with Trip Pro

2017 Current Opinion in Neurology

92. Spontaneous Bilateral Internal Carotid Artery Dissections in a Young Female with Headache (PubMed)

Spontaneous Bilateral Internal Carotid Artery Dissections in a Young Female with Headache Spontaneous cervical artery dissection (sCAD) occurs when the intimal lining separates from the outer wall of the artery. Although rare, it is a common cause of stroke in young people. Presentations range from isolated headache to severe stroke symptoms. A 41-year-old woman with minimal past medical history presented with left-sided headache and transient right leg weakness and numbness. The patient

Full Text available with Trip Pro

2017 Clinical Practice and Cases in Emergency Medicine

93. Psychiatric Comorbidities and Environmental Triggers in Patients with Chronic Daily Headache: A Lifestyle Study (PubMed)

Psychiatric Comorbidities and Environmental Triggers in Patients with Chronic Daily Headache: A Lifestyle Study Objective: Patients with chronic daily headache (CDH) suffer from several significant psychiatric comorbidities and have unhealthy lifestyle. We aimed at studying psychiatric comorbidities, environmental triggers, lifestyle factors, and intensity of CDH in patients referred by the department of neurology from 2011 to 2014. Method: Through medical and psychiatric interviews and using 0 (...) to 10 visual analogue scale (VAS), we assessed patients with CDH, using a checklist, to elicit psychiatric comorbidities, intensity of CDH, environmental factors, and lifestyle derangement. Results: We interviewed 413 (age 16-80 years, mean 40 +/- 14.0) out of 548 patients; 312 (75.5%) were married, and 282 (68.1%) were female. Environmental triggers (374, 90.6%) were the most common cause of CDH, while 214 (51.8%) had no compliance to recommended nutrition. Exercise avoidance (201, 48.7

Full Text available with Trip Pro

2017 Iranian journal of psychiatry

94. Migraine headache in patients with idiopathic intracranial hypertension (PubMed)

Migraine headache in patients with idiopathic intracranial hypertension Migraine is a neurological disorder that afflicts many people in the world and can cause severe disability during the attacks. The pathophysiology of migraine is complex and not fully understood. It seems that migraine is common in idiopathic intracranial hypertension (IIH). However, the association between migraine headache and IIH is still unclear. The present study was conducted to assess the prevalence of migraine (...) headache and associated factors in IIH patients. In this cross-sectional study, a total of 68 patients diagnosed with IIH underwent a medical history interview and a neurological examination. The diagnosis of migraine was based on the four diagnostic criteria of the International Classification of Headache Disorders 3rd edition. Forty-five patients (63.2%) met the diagnostic criteria of migraine headache. There was no significant difference between patients with and without migraine headache in respect

Full Text available with Trip Pro

2017 Neurology international

95. GPs' experiences with brief intervention for medication-overuse headache: a qualitative study in general practice. (PubMed)

in Norwegian general practice.Data were collected through four focus group interviews with 22 GPs who participated in an intervention study on BI for MOH. Systematic text condensation was used to analyse transcripts from the focus group interviews.The GPs experienced challenges when trying to convince patients that the medication they used to treat and prevent headache could cause headache, but labelling MOH as a diagnosis opened up a space for change. GPs were able to use BI within the scope of a regular (...) GPs' experiences with brief intervention for medication-overuse headache: a qualitative study in general practice. Medication-overuse headache (MOH) is common in the general population, and most patients are managed in primary health care. Brief Intervention (BI) has been used as a motivational technique for patients with drug and alcohol overuse, and may a have role in the treatment of MOH.To explore GPs' experiences using BI in the management of patients with MOH.Qualitative study

Full Text available with Trip Pro

2014 British Journal of General Practice

96. Medication Overuse Headache: Self-Perceived and Actual Knowledge Among Pharmacy Staff. (PubMed)

(90.6%) considered themselves to have knowledge about MOH to some or a greater extent. Almost half had learned about MOH through their university/vocational education. Only 8.6% knew that all 5 headache medications listed in the questionnaire can cause development of MOH, but 40% responded correctly on which treatment advice one can give a person with MOH. Actual knowledge on treatment advice differed significantly between groups of self-perceived knowledge.The knowledge on MOH is insufficient among (...) Medication Overuse Headache: Self-Perceived and Actual Knowledge Among Pharmacy Staff. The aim of this study was to investigate knowledge about medication overuse headache (MOH) among pharmacy staff.MOH is a public health problem both in Sweden and in many other countries. Persons with MOH have limited contact with health care, and medications used are to large extent over-the-counter (OTC) medications. Therefore, pharmacists have an important role in, eg, advising these individuals about

Full Text available with Trip Pro

2014 Headache

97. Headache, Diagnosis and Treatment of

: Subacute and/or progressive headaches that worsen over time (months) A new or different headache Any headache of maximum severity at onset Headache of new onset after age 50 Persistent headache precipitated by a Valsalva maneuver Evidence such as fever, hypertension, myalgias, weight loss or scalp tenderness suggesting a systemic disorder Presence of neurological signs that may suggest a secondary cause Seizures Migraine-associated symptoms are often misdiagnosed as “sinus headache” by patients (...) and clinicians. Most headaches characterized as “sinus headaches” are migraines. Early treatment of migraines with effective medications improves a variety of outcomes including duration, severity and associated disability. Drug treatment of acute headache should generally not exceed more than two days per week on a regular basis. More frequent treatment other than this may result in medication-overuse chronic daily headaches. Inability to work or carry out usual activities during a headache is an important

2013 Institute for Clinical Systems Improvement

98. Chronic pain disorder medical treatment guideline.

events. It is also likely that both transdermal medications cause less constipation than oral morphine (Design: Network meta-analysis of randomized clinical trials ). In the setting of common low back injuries, when baseline pain and injury severity are taken into account, a prescription for more than seven days of opioids in the first 6 weeks is associated with an approximate doubling of disability one year after the injury (Design: Prospective cohort study ). Some Evidence Long-acting oxycodone (...) Chronic pain disorder medical treatment guideline. Chronic pain disorder medical treatment guideline. | National Guideline Clearinghouse success fail May JUN 09 2017 2018 2019 08 Jun 2018 - 12 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed

2017 National Guideline Clearinghouse (partial archive)

99. Complex regional pain syndrome/reflex sympathetic dystrophy medical treatment guideline.

probably causes significantly less nausea than fentanyl, and it probably carries a lower risk of treatment discontinuation due to adverse events. It is also likely that both transdermal medications cause less constipation than oral morphine (Design: Network meta-analysis of randomized clinical trials ). In the setting of common low back injuries, when baseline pain and injury severity are taken into account, a prescription for more than 7 days of opioids in the first 6 weeks is associated (...) Complex regional pain syndrome/reflex sympathetic dystrophy medical treatment guideline. Complex regional pain syndrome/reflex sympathetic dystrophy medical treatment guideline. | National Guideline Clearinghouse success fail May JUN Jul 09 2017 2018 2019 08 Jun 2018 - 09 Jun 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites

2017 National Guideline Clearinghouse (partial archive)

100. Drugs That May Cause or Exacerbate Heart Failure

to 23 different providers annually in both the inpatient and outpatient settings, which could in turn increase the number of prescription medications prescribed. As the number of prescription medications increases, so does the potential for adverse drug events and drug-drug interactions. Goldberg et al found that patients taking at least 2 prescription medications had a 13% risk of an adverse drug-drug interaction, which increased to 38% for 4 medications and 82% with ≥7 medications. Drugs may cause (...) or exacerbate HF by causing direct myocardial toxicity; by negative inotropic, lusitropic, or chronotropic effects; by exacerbating hypertension; by delivering a high sodium load; or by drug-drug interactions that limit the beneficial effects of HF medications. To avoid these negative effects, healthcare providers need a comprehensive and accessible guide of the prescription medications, OTC medications, and CAMs that could exacerbate HF. Using case reports, case series, package inserts, meta-analyses

Full Text available with Trip Pro

2016 American Heart Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>